Janux Therapeutics, Inc. SEC filings JANX
Janux Therapeutics, Inc. has 442 filings in SEC EDGAR's recent list, going back to Jul 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2022 | — |
| EFFECT | Filing | Jun 10, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 10, 2021 | — |
| CERT | Filing | Jun 10, 2021 | — |
| 8-A12B | Filing | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 7, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 1, 2021 | — |
| UPLOAD | Letter from the SEC | May 28, 2021 | — |
| CORRESP | Letter to the SEC | May 19, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| SEC STAFF LETTER | Filing | May 12, 2021 | — |
| D | Filing | Apr 30, 2021 | — |
| DRS | Filing | Apr 16, 2021 | — |
| D | Filing | Mar 12, 2021 | — |
| D | Filing | Jul 14, 2020 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JANX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1817713
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.